Archives
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-11
- 2018-10
- 2018-07
-
SHC-1 Inhibition and CFTR Surface Trafficking
2026-08-13
Barros and colleagues show that MAPK/SHC-1-dependent internalization of CFTR is detectable across airway and intestinal epithelial models, but that pharmacological SHC-1 inhibition increases surface CFTR selectively in CFBE cells. The study highlights cell-line-specific trafficking biology and cautions that higher plasma membrane abundance may occur alongside broader changes in membrane protein distribution.
-
HBsAg Hijacks TBK1 to Suppress IFN and Induce Autophagy
2026-08-13
The reference study identifies a mechanism by which hepatitis B surface antigen redirects TBK1 activity away from IRF3-dependent interferon production toward p62 phosphorylation and early autophagy. Its combination of molecular interaction studies, BX795 perturbation, animal models, and human liver tissue analysis links incomplete autophagy with HBV immune evasion and persistence.
-
EZ Cap™ Cas9 mRNA (m1Ψ) Workflow
2026-08-12
Build transient, controllable CRISPR-Cas9 assays with a Cap1-capped, m1Ψ-modified transcript designed for efficient translation and reduced innate immune sensing. This workflow also shows how nuclear-export biology can be added as a precision-control variable in genome editing in mammalian cells.
-
Pronase E for Mechanism-Ready Proteomics
2026-08-12
Pronase E is a broad-spectrum protease mixture for protein digestion, peptide mapping, and molecular biology workflows. This guide explains how to use its analytical strengths without confusing sample preparation evidence with direct proof of the CUL3–MTDH ferroptosis mechanism.
-
miR-18a, ALOXE3, and Ferroptosis in Glioblastoma
2026-08-11
The reference study identifies a miR-18a/ALOXE3 regulatory axis that links ferroptosis resistance with glioblastoma growth and migration. Its combination of human tumor analysis, genetic perturbation, orthotopic modeling, and lipid mediator studies provides a mechanistic framework for investigating ferroptosis in glioblastoma and related cancer biology research.
-
Gasdermin C in Pancreatic Cancer: Stemness and Escape
2026-08-11
A 2024 Advanced Science study identifies Gasdermin C (GSDMC) as a nuclear regulator of pancreatic ductal adenocarcinoma stemness, metastasis, and immune evasion rather than only a pyroptosis-associated pore-forming protein. The work links ADAM17-dependent GSDMC cleavage to transcriptional reprogramming and shows that blocking cleavage or nuclear translocation can improve responses to KRASG12D inhibition and PD-1 checkpoint blockade in preclinical models.
-
IWR-1-endo: A Morphology-First Assay Strategy
2026-08-10
IWR-1-endo is a potent Wnt signaling inhibitor that can be evaluated through a morphology-first, mechanism-aware workflow. This guide connects pathway perturbation with high-content phenotyping, using cardiomyocyte profiling research to clarify assay design, controls, and translational limits.
-
Caspase-3 Fluorometric Assay Kit Guide
2026-08-09
The Caspase-3 Fluorometric Assay Kit provides quantitative DEVD-dependent caspase-3 activity measurement through AFC fluorescence. Its one-step, 1–2-hour workflow supports apoptosis assay development, while pathway interpretation requires appropriate controls and orthogonal cell-death measurements.
-
SHC-1 Inhibition and CFTR Surface Trafficking
2026-08-08
Barros et al. show that MAPK/SHC-1-dependent internalization of CFTR is conserved across airway and intestinal epithelial models, but that pharmacological SHC-1 inhibition increases surface CFTR only in CFBE cells. The study highlights both a potentially actionable trafficking pathway and the importance of validating CFTR regulation across cell backgrounds and with selectivity controls.
-
PPM-18 for Mechanistic Inflammation Assays
2026-08-07
PPM-18 is an iNOS expression inhibitor that helps researchers dissect NF-κB-dependent inflammatory signaling. This article presents a phenotype-to-mechanism assay strategy inspired by osteoimmune research, while clearly separating established evidence from experimental hypotheses.
-
Temporal Coordination of Transcription Factors in H2O2 Stres
2026-08-07
This study uncovers how mammalian cells temporally coordinate transcription factor activation in response to varying hydrogen peroxide (H2O2) levels. By dissecting the dose- and time-dependent activation of key factors, the findings reveal new insights into oxidative stress adaptation with implications for disease models and redox biology research.
-
Sulfur Transport Delays Soybean Nodule Senescence via NO Reg
2026-08-06
A recent study reveals that sulfur supply to soybean symbiosomes, mediated by SULTR transporters, is essential for delaying nodule senescence by sustaining glutathione and mitigating reactive nitrogen species (RNS) accumulation. These findings provide mechanistic insight for optimizing symbiotic nitrogen fixation and sustainable crop yields through nutrient management and genetic strategies.
-
Rapamycin (Sirolimus): Applied Workflows for mTOR Pathway Re
2026-08-06
Rapamycin (Sirolimus) offers nanomolar potency and exceptional specificity for dissecting mTOR signaling, making it a gold-standard tool for research in cancer biology, immunology, and mitochondrial disease models. This guide provides practical workflows, troubleshooting strategies, and expert insights based on recent literature, including direct translation of innovations from the latest ferroptosis research.
-
LEE011 Succinate: Advanced CDK Inhibitor Workflows in Cancer
2026-08-05
Ribociclib succinate (LEE011 succinate) enables reproducible cell cycle arrest and robust antineoplastic workflows, even under challenging conditions. This guide delivers advanced protocols, troubleshooting tips, and evidence-backed insights to maximize its impact in cancer research.
-
AL-8810: Prostaglandin F2α Antagonist for Advanced Endometri
2026-08-05
AL-8810, a selective prostaglandin F2α antagonist, empowers precise modulation of FP receptor pathways in models of vascular and endometrial dynamics. This guide translates cutting-edge research into actionable protocols, troubleshooting tips, and comparative insights for researchers dissecting prostaglandin-mediated mechanisms.